BCMAxCD3 Bispecific Antibody Elranatamab Is Effective in Patient Myeloma Relapsed after BCMA CAR-T

被引：2
|
作者：
Keller, Alana L. [1 ]
Parzych, Sarah E. [1 ]
Reiman, Lauren T. [1 ]
Walker, Zachary J. [1 ]
Forsberg, Peter A. [2 ]
Sherbenou, Daniel W. [1 ]
机构：
[1] Univ Colorado, Div Hematol, Anschutz Med Campus, Aurora, CO USA
[2] Univ Colorado, Div Hematol, Hlth Blood Disorders & Cell Therapies Ctr, Aurora, CO USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-187385
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy
    Samer Al Hadidi
    Aniko Szabo
    Jean Esselmann
    Lindsay Hammons
    Munawwar Hussain
    Yetunde Ogunsesan
    Nishanth Thalambedu
    Fatima Khan
    Jaskirat Sethi
    Abhishek Janardan
    Sabarinath Venniyil Radhakrishnan
    Sharmilan Thanendrarajan
    Carolina Schinke
    Binod Dhakal
    Siegfried Janz
    Saurabh Chhabra
    Anita D’Souza
    Maurizio Zangari
    Frits van Rhee
    Meera Mohan
    Bone Marrow Transplantation, 2023, 58 : 443 - 445
  • [42] Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy
    Al Hadidi, Samer
    Szabo, Aniko
    Esselmann, Jean
    Hammons, Lindsay
    Hussain, Munawwar
    Ogunsesan, Yetunde
    Thalambedu, Nishanth
    Khan, Fatima
    Sethi, Jaskirat
    Janardan, Abhishek
    Radhakrishnan, Sabarinath Venniyil
    Thanendrarajan, Sharmilan
    Schinke, Carolina
    Dhakal, Binod
    Janz, Siegfried
    Chhabra, Saurabh
    D'Souza, Anita
    Zangari, Maurizio
    van Rhee, Frits
    Mohan, Meera
    BONE MARROW TRANSPLANTATION, 2023, 58 (04) : 443 - 445
  • [43] Bispecific CAR-T Cells Targeting Both BCMA and CD24: A Potentially Treatment Approach for Multiple Myeloma
    Sun, Fumou
    Cheng, Yan
    Peng, Bailu
    Xu, Hongwei
    van Rhee, Frits
    Janz, Siegfried
    Tricot, Guido
    Shaughnessy, John D., Jr.
    Zhan, Fenghuang
    BLOOD, 2021, 138
  • [44] Single VHH-directed BCMA CAR-T cells cause remission of relapsed/refractory multiple myeloma
    Han, Lu
    Zhang, Ji-Shuai
    Zhou, Jian
    Zhou, Ke-Shu
    Xu, Ben-Ling
    Li, Lin-Lin
    Fang, Bai-Jun
    Yin, Qing-Song
    Zhu, Xing-Hu
    Zhou, Hu
    Wei, Xu-Dong
    Su, Hong-Chang
    Zhang, Bing-Xiang
    Wang, Ya-Nan
    Xiang, Bin
    Gao, Quan-Li
    Song, Yong-Ping
    LEUKEMIA, 2021, 35 (10) : 3002 - 3006
  • [45] Systematically optimized BCMA/CS1 bispecific CAR-T cells robustly control heterogeneous multiple myeloma
    Zah, Eugenia
    Nam, Eunwoo
    Bhuvan, Vinya
    Tran, Uyen
    Ji, Brenda Y.
    Gosliner, Stanley B.
    Wang, Xiuli
    Brown, Christine E.
    Chen, Yvonne Y.
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [46] Systematically optimized BCMA/CS1 bispecific CAR-T cells robustly control heterogeneous multiple myeloma
    Eugenia Zah
    Eunwoo Nam
    Vinya Bhuvan
    Uyen Tran
    Brenda Y. Ji
    Stanley B. Gosliner
    Xiuli Wang
    Christine E. Brown
    Yvonne Y. Chen
    Nature Communications, 11
  • [47] Immunotherapy-Based Treatment Options in Relapsed/Refractory Multiple Myeloma: Updated Results from Phase 1b Trial of Combination Therapy with Daratumumab and Teclistamab (BCMAxCD3 Bispecific Antibody)
    Waesch, R.
    Rodriguez-Otero, P.
    D'Souza, A.
    Reece, D.
    Van De Donk, N. W.
    Chari, A.
    Krishnan, A.
    Martin, T.
    Mateos, M., V
    Morillo, D.
    Hurd, D.
    Rosinol, L.
    Balari, A. S.
    Vishwamitra, D.
    Wang, Lin S. X.
    Prior, T.
    Vandenberk, L.
    Smit, Damiette M. -A
    Oriol, A.
    Dholaria, B.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 248 - 249
  • [48] Canadian-made single domain antibody (sdAb) BCMA CAR-T cells for multiple myeloma
    Lindo, Lorenzo
    Waller, Daniel
    Wilkinson, Lauren
    Selleri, Silvia
    Arbabi-Ghahroudi, Mehdi
    McComb, Scott
    Bergsagel, Leif
    Chesi, Marta
    Hay, Kevin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S48 - S49
  • [49] Salvage therapies including retreatment with BCMA-directed approaches after BCMA CAR-T relapses for multiple myeloma
    Reyes, Kevin R.
    Liu, Yen-Chun
    Huang, Chiung-Yu
    Banerjee, Rahul
    Martin, Thomas
    Wong, Sandy W.
    Wolf, Jeffrey L.
    Arora, Shagun
    Shah, Nina
    Chari, Ajai
    Chung, Alfred
    BLOOD ADVANCES, 2024, 8 (09) : 2207 - 2216
  • [50] CAR-T Cells Based on Novel BCMA Monoclonal Antibody Block Multiple Myeloma Cell Growth
    Berahovich, Robert
    Zhou, Hua
    Xu, Shirley
    Wei, Yuehua
    Guan, Jasper
    Guan, Jian
    Harto, Hizkia
    Fu, Shuxiang
    Yang, Kaihuai
    Zhu, Shuying
    Li, Le
    Wu, Lijun
    Golubovskaya, Vita
    CANCERS, 2018, 10 (09)
12345